Generic Atrovent Inhalation Solution

While brand-name Atrovent inhalation solution is no longer manufactured, there is a generic version of the medication available. Generic Atrovent inhalation solution comes in only one strength -- ipratropium bromide 0.02% inhalation solution. Actavis Mid Atlantic, Aslung Pharmaceuticals, and Teva Pharmaceuticals are among the companies that currently make a generic Atrovent inhalation solution.

 

Generic Atrovent Inhalation Solution: An Overview

Atrovent® inhalation solution (ipratropium bromide inhalation solution) is a prescription medication used to treat chronic obstructive pulmonary disease (COPD). Atrovent inhalation solution belongs to a group of medications known as anticholinergics or antimuscarinics. There are several different forms of Atrovent (including Atrovent nasal spray and Atrovent HFA inhalers). Atrovent inhalation solution is a form of Atrovent that is inhaled using a device called a nebulizer.
 
Atrovent inhalation solution was originally made by Boehringer Ingelheim Pharmaceuticals. However, brand-name Atrovent inhalation solution is no longer manufactured. Fortunately, generic Atrovent inhalation solution is still available.
 

Who Makes Generic Atrovent Inhalation Solution?

Generic Atrovent inhalation solution is made by the following companies:
 
  • Actavis Mid Atlantic
  • Apotex, Corp.
  • Aslung Pharmaceuticals
  • Cobalt Laboratories
  • DEY
  • Nephron Pharmaceuticals Corporation
  • RxElite Holdings
  • Teva Pharmaceuticals.
     

Generic Atrovent Inhalation Solution Strengths

Generic Atrovent inhalation solution comes in only one strength -- ipratropium bromide 0.02% inhalation solution (containing 500 mcg of ipratropium bromide per 2.5 mL single-use vial). However, there are different sizes of packages available for this product, with 25, 30, 60, or 120 vials per package.
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;